Physician
Palumbo, Linda
Palumbo, Linda was paid $4.25M by Medicaid between Jan 2018 and Dec 2023, across 57 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoPALUMBO, LINDA
CHICAGO, IL 60527
CHICAGO, IL 60527
33aNPI1215994264assigned 04/26/2006
33bProvider typeInternal Medicine Physician
28Total paid$4.25M
24GClaims112,622
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Internal Medicine Physician providers in Illinois
Rank by total paid#3 of 3,722
Median peer was paid$26K
This provider vs. median165×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,238 | $101K | |
| 2019 | 24,073 | $821K | |
| 2020 | 29,011 | $1.00M | |
| 2021 | 35,770 | $1.48M | |
| 2022 | 20,314 | $840K | |
| 2023 | 216 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 20,778 | 16,064 | $1.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 14,733 | 11,695 | $667K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 8,167 | 6,717 | $603K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.3% | 8,644 | 7,633 | $354K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.7% | 6,313 | 4,964 | $284K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.6% | 8,522 | 6,646 | $239K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 6,337 | 5,278 | $98K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 3,554 | 3,246 | $89K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 1,128 | 969 | $58K |
| 99000 | <1% | 2,472 | 1,845 | $42K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 487 | 384 | $40K |
| 87808 | <1% | 2,130 | 1,595 | $33K |
45 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 967 | $32K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 505 | $30K |
| 81025 | <1% | 6,175 | $25K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 674 | $22K |
| 87905 | <1% | 2,108 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,771 | $17K |
| 81002 | <1% | 6,786 | $17K | |
| 93000 | <1% | 766 | $16K | |
| 99205 | Prolong outpt/office vis | <1% | 121 | $13K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 208 | $11K |
| 99385 | <1% | 98 | $10K | |
| 87807 | <1% | 971 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 498 | $8K |
| 86318 | <1% | 486 | $8K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 92 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 56 | $4K |
| 99384 | <1% | 47 | $4K | |
| 90715 | <1% | 144 | $3K | |
| 99383 | <1% | 33 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 160 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,298 | $2K |
| 90756 | <1% | 137 | $1K | |
| 73630 | <1% | 68 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $1K |
| 99382 | <1% | 12 | $984.30 | |
| 73610 | <1% | 37 | $947.96 | |
| 72100 | <1% | 34 | $947.10 | |
| 86580 | <1% | 192 | $813.54 | |
| 83655 | <1% | 50 | $593.00 | |
| 90688 | <1% | 35 | $583.12 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 313 | $564.22 |
| 73130 | <1% | 29 | $554.25 | |
| 69210 | <1% | 21 | $385.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 249 | $243.83 |
| 82962 | <1% | 123 | $213.32 | |
| 36416 | <1% | 121 | $200.90 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $153.98 |
| 86308 | <1% | 13 | $62.40 | |
| 94760 | <1% | 156 | $48.40 | |
| 99051 | <1% | 758 | $7.50 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 35 | $4.55 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 32 | $3.70 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 12 | $0.00 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 801 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 138 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.